pT22gCfpUbiG4FER4P2A(#249)
(Plasmid
#184070)
-
Purposecyclofen-inducible GAL4 activation in zebrafish permanent transgenic
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 184070 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepT22i (pT2AL200R150G derivative)
-
Backbone manufacturermodified by M Volovitch from pT2AL200R150 of A Urasaki; Urasaki et al 2006, Genetics 174:639)
- Backbone size w/o insert (bp) 8042
-
Vector typeZebrafish transgenesis (blue eyes)
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameGal4bdFF-ERT2-P2A
-
SpeciesS. cerevisiae (Gal4bd), Herpes Simplex Virus (F), H. sapiens (ERT2), PTV-1 (P2A)
-
Insert Size (bp)1584
-
MutationERT2: G400V, M543A, L544A, deleted 1-281;
- Promoter Zf-Ubi
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BamHI (not destroyed)
- 3′ cloning site SnaBI (not destroyed)
- 5′ sequencing primer ubidir
- 3′ sequencing primer SVLrev34 (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made bysynthetic ERT2
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Gal4FF: AJD87368; ERT2: NP_000116; P2A: AIE57569; + gCRY:CFP as a marker of transgenesis
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pT22gCfpUbiG4FER4P2A(#249) was a gift from Sophie Vriz (Addgene plasmid # 184070 ; http://n2t.net/addgene:184070 ; RRID:Addgene_184070) -
For your References section:
Optical Control of Tumor Induction in the Zebrafish. Feng Z, Nam S, Hamouri F, Aujard I, Ducos B, Vriz S, Volovitch M, Jullien L, Lin S, Weiss S, Bensimon D. Sci Rep. 2017 Aug 23;7(1):9195. doi: 10.1038/s41598-017-09697-x. 10.1038/s41598-017-09697-x PubMed 28835665